Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Ibuprofen for IUD Continuation
NCT00243815Phase 3Completed
- Sponsor
- FHI 360
- Start
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dysmenorrhea and Menorrhagia comparing Ibuprofen with Placebo (2 arms). Primary endpoint: IUD removal rate at 12 months. Started Jun 2002; status: completed.
02
Drugs
ibuprofen
03
Conditions
dysmenorrheaMenorrhagia
Beyond the preview
Go deeper on NCT00243815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243815.